Shahid Khan of Leiden University Medical Centre in the Netherlands seeks to produce a multi-stage malaria vaccine using transgenic sporozoites. These parasite forms will also present transmission blocking antigens to not only generate protective immunity against early stages of infection, but also generate antibodies to block transmission via mosquitoes.
Grant ID
OPP1008310
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False